SCHEMBL14295619

SCHEMBL14295619

c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccc(-c5ccc(N(c6ccccc6)c6cccc7c6oc6c(-c8ccccc8)cccc67)cc5)cc4)cc3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.37
▸ PRKDC P78527 7/20 0.35
▸ ALDH1A1 P00352 4/20 0.34
▸ PIK3CD O00329 3/20 0.34
▸ PIK3CA P42336 3/20 0.34
▸ PIK3CB P42338 3/20 0.34
▸ PIK3CG P48736 3/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ BRD4 O60885 2/20 0.34
▸ BRD2 P25440 2/20 0.34
▸ BRD3 Q15059 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ PDE2A O00408 1/20 0.34
▸ PIK3C2A O00443 1/20 0.34
▸ PIK3R2 O00459 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14295613 1.00 ALOX5 (0.37) ALOX5PRKDCALDH1A1PIK3CDPIK3CA
SCHEMBL14295556 0.99 ALOX5 (0.38) ALOX5PRKDCALDH1A1PIK3CDPIK3CA
SCHEMBL17703159 0.99 ALOX5 (0.38) ALOX5PRKDCALDH1A1PIK3CDPIK3CA
SCHEMBL17703153 0.97 ALOX5 (0.38) ALOX5PRKDCALDH1A1PIK3CDPIK3CA
SCHEMBL24370047 0.94 ALOX5 (0.38) ALOX5PRKDCALDH1A1PIK3CDPIK3CA
SCHEMBL22140592 0.94 PRKDC (0.38) ALOX5PRKDCALDH1A1PIK3CDPIK3CA
SCHEMBL19103185 0.94 CA12 (0.38) ALOX5PRKDCALDH1A1PIK3CDPIK3CA
SCHEMBL19103163 0.93 ALOX5 (0.41) ALOX5PRKDCALDH1A1PIK3CDPIK3CA
SCHEMBL20341951 0.93 ALDH1A1 (0.37) ALDH1A1KDM4ESMN1; SMN2CYP1A2CYP3A4
SCHEMBL17703074 0.93 ALOX5 (0.41) ALOX5PRKDCALDH1A1PIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 — — US disclosed
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME INMT, TYR, ALKBH2 ALOX5 1298/4885PRKDC 1023/4885ALDH1A1 890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback